COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01083966
Recruitment Status : Suspended (In the process of transferring IRB to PI's current institution.)
First Posted : March 10, 2010
Last Update Posted : September 10, 2020
Feinstein Institute for Medical Research
Hofstra North Shore
Information provided by (Responsible Party):
John Boockvar, MD Zucker SOM @Hofstra/Northwell, Feinstein Institute for Medical Research

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022